Sign in

Tango Therapeutics, Inc.

Income Statement - Tango Therapeutics, Inc. (TNGX)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total revenue 0.06 0.04 0.04 0.02 0.04 0.01 0.02
Cost of revenue 0.00 0.00 0.12 0.00 0.00 0.00 0.03
Gross profit 0.06 0.04 0.04 0.02 0.04 0.01 -0.01
Total operating expenses + 0.17 0.19 0.15 0.14 0.10 0.06 0.01
Operating income -0.11 -0.15 -0.11 -0.11 -0.06 -0.05 -0.02
Non-operating income (net) 0.01 0.02 0.01 0.00 0.00 0.00 0.00
Income before tax -0.10 -0.13 -0.10 -0.11 -0.06 -0.05 -0.01
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.10 -0.13 -0.10 -0.11 -0.06 -0.05 -0.01
Show Quarterly Income Statement

Income Statement - Tango Therapeutics, Inc. (TNGX)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total revenue 0.00 0.00 0.05 0.00 0.01 0.00 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 -0.01 0.01 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.01 0.01 0.01
Gross profit 0.00 0.00 0.05 0.00 0.01 0.00 0.01 0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.01 0.01 0.01 -0.02 0.02 0.01 0.01 -0.02 -0.01 -0.01
Total operating expenses + 0.05 0.04 0.04 0.04 0.05 0.05 0.04 0.05 0.05 0.04 0.04 0.04 0.03 0.04 0.04 0.03 0.03 0.03 0.00 0.02 0.02 0.02 0.00 0.00 0.00
Operating income -0.05 -0.04 0.01 -0.04 -0.04 -0.04 -0.03 -0.03 -0.04 -0.04 -0.03 -0.02 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 0.00 -0.01 -0.01 -0.03 -0.01 -0.01
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.05 -0.04 0.02 -0.04 -0.04 -0.04 -0.03 -0.03 -0.04 -0.03 -0.02 -0.02 -0.03 -0.03 -0.03 -0.02 -0.03 -0.02 -0.02 0.00 -0.01 -0.01 -0.03 -0.01 -0.01
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.05 -0.04 0.02 -0.04 -0.04 -0.04 -0.03 -0.03 -0.04 -0.03 -0.02 -0.02 -0.03 -0.03 -0.03 -0.02 -0.03 -0.02 -0.02 0.00 -0.01 -0.01 -0.03 -0.01 -0.01
4 days ago

Balance Sheet - Tango Therapeutics, Inc. (TNGX)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total cash and short-term investments + 0.34 0.26 0.34 0.37 0.49 0.19 0.04
Accounts receivable, net 0.00 0.00 0.00 0.00
Inventories 0.00 0.00
Other current assets 0.01 0.01 0.01 0.01 0.01 0.00 0.00
Total current assets 0.35 0.27 0.35 0.38 0.49 0.19 0.04
Total non-current assets + 0.04 0.05 0.06 0.06 0.01 0.01 0.01
Total assets 0.40 0.32 0.40 0.44 0.50 0.21 0.06
Total current liabilities + 0.02 0.04 0.05 0.06 0.04 0.04 0.03
Total non-current liabilities + 0.03 0.08 0.10 0.13 0.11 0.13 0.02
Total liabilities 0.05 0.12 0.15 0.19 0.16 0.17 0.05
Total stockholders' equity + 0.35 0.20 0.25 0.25 0.34 0.04 0.01
Common shares outstanding 116 109 95 88 62 87 87
Show Quarterly Balance Sheet

Balance Sheet - Tango Therapeutics, Inc. (TNGX)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total cash and short-term investments + 0.38 0.34 0.15 0.18 0.22 0.26 0.29 0.32 0.34 0.34 0.36 0.31 0.33 0.37 0.39 0.42 0.45 0.49 0.50 0.20 0.21 0.19 0.17 0.00 0.04
Accounts receivable, net 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Total current assets 0.39 0.35 0.16 0.19 0.22 0.27 0.30 0.33 0.35 0.35 0.37 0.32 0.34 0.38 0.40 0.44 0.46 0.49 0.52 0.20 0.21 0.19 0.00 0.00 0.04
Total non-current assets + 0.04 0.04 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.06 0.06 0.06 0.06 0.06 0.06 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.17 0.00 -0.04
Total assets 0.44 0.40 0.21 0.24 0.27 0.32 0.35 0.38 0.41 0.40 0.43 0.38 0.40 0.44 0.46 0.45 0.47 0.50 0.53 0.22 0.22 0.21 0.17 0.00
Total current liabilities + 0.01 0.02 0.02 0.04 0.04 0.04 0.04 0.04 0.04 0.05 0.04 0.05 0.05 0.06 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.00 0.00
Total non-current liabilities + 0.03 0.03 0.03 0.06 0.07 0.08 0.09 0.09 0.10 0.10 0.11 0.11 0.12 0.13 0.14 0.11 0.11 0.11 0.12 0.13 0.13 0.13 0.01
Total liabilities 0.04 0.05 0.05 0.10 0.11 0.12 0.12 0.13 0.14 0.15 0.15 0.17 0.18 0.19 0.19 0.15 0.15 0.16 0.16 0.16 0.17 0.17 0.01 0.00
Total stockholders' equity + 0.39 0.35 0.16 0.13 0.17 0.20 0.23 0.25 0.26 0.25 0.28 0.21 0.23 0.25 0.27 0.30 0.32 0.34 0.37 0.05 0.06 0.04 0.16 0.00 0.01
Common shares outstanding 144 116 111 111 110 109 109 108 108 96 97 88 88 88 88 88 88 88 70 87 87 87 87 87 87
4 days ago

Cash Flow - Tango Therapeutics, Inc. (TNGX)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Operating cash flow + -0.14 -0.13 -0.12 -0.11 -0.06 0.07 -0.02
Cash flow from investing + -0.04 0.09 0.04 0.03 -0.18 -0.15 0.00
Cash flow from financing + 0.22 0.05 0.08 0.00 0.36 0.08 0.01
Change in cash 0.04 0.00 0.01 -0.08 0.11 0.01 -0.01
Show Quarterly Cash Flow

Cash Flow - Tango Therapeutics, Inc. (TNGX)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Operating cash flow + -0.04 -0.03 -0.03 -0.04 -0.04 -0.04 -0.03 -0.02 -0.04 -0.03 -0.03 -0.02 -0.03 -0.03 -0.02 -0.03 -0.03 -0.02 -0.02 -0.01 -0.01 -0.02 0.11 -0.01 -0.01
Cash flow from investing + 0.01 -0.14 0.05 0.02 0.03 0.05 0.03 0.01 -0.01 0.03 -0.06 0.03 0.03 -0.01 0.02 0.04 -0.01 -0.05 -0.15 -0.01 0.02 -0.06 -0.07 -0.03 0.01
Cash flow from financing + 0.08 0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.00 0.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.33 0.00 0.03 0.00 0.05 0.03 0.03
Change in cash 0.05 0.05 0.02 -0.02 -0.01 0.02 0.00 -0.01 -0.01 0.01 -0.01 0.01 0.00 -0.04 0.00 0.00 -0.04 -0.06 0.15 -0.01 0.04 -0.08 0.09 -0.01 0.03
4 days ago

Tango Therapeutics, Inc. (TNGX) - Operating Cashflow

1Y 2Y 5Y Max
9 days ago

Tango Therapeutics, Inc. (TNGX) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
9 days ago

Tango Therapeutics, Inc. (TNGX) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
9 days ago

Tango Therapeutics, Inc. (TNGX) - Change In Inventory

1Y 2Y 5Y Max
9 days ago

Tango Therapeutics, Inc. (TNGX) - Net Income

1Y 2Y 5Y Max
9 days ago

Tango Therapeutics, Inc. (TNGX) - Stock Based Compensation

1Y 2Y 5Y Max
9 days ago

Tango Therapeutics, Inc. (TNGX) - Cashflow From Financing

1Y 2Y 5Y Max
9 days ago

Tango Therapeutics, Inc. (TNGX) - Cashflow From Investment

1Y 2Y 5Y Max
9 days ago

Tango Therapeutics, Inc. (TNGX) - Capital Expenditures

1Y 2Y 5Y Max
9 days ago

Tango Therapeutics, Inc. (TNGX) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
9 days ago